589 results on '"Stankoff, Bruno"'
Search Results
102. Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
103. Comparative effectiveness of natalizumab and fingolimod in subgroups of patients with relapsing-remitting multiple sclerosis from three international cohorts (2943)
104. Choroid plexus enlargement characterizes inflammatory multiple sclerosis (2522)
105. Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis
106. Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey
107. MSJ921362_supplement_3 – Supplemental material for Thalamic energy dysfunction is associated with thalamo-cortical tract damage in multiple sclerosis: A diffusion spectroscopy study
108. Des agents neuroprotecteurs au concept de traitement modulateur du cours évolutif des maladies cérébrales
109. Neuroprotection: Present and future
110. Imaging of CNS myelin by positron-emission tomography
111. Inflammation‐driven glial alterations in the cuprizone mouse model probed with diffusion‐weighted magnetic resonance spectroscopy at 11.7 T
112. Determinants of therapeutic lag in multiple sclerosis
113. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4′-methylaminophenyl)- 6-hydroxybenzothiazole
114. Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair
115. L’inhibition de la tyrosine kinase de Bruton (BTK) favorise la réparation de la myéline dans deux modèles différents de démyélinisation
116. Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion
117. Identifying Progression in Multiple Sclerosis: New Perspectives
118. Thalamic energy dysfunction is associated with thalamo-cortical tract damage in multiple sclerosis: A diffusion spectroscopy study
119. Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019)
120. Problems and Pitfalls of Identifying Remyelination in Multiple Sclerosis
121. Bruton’s Tyrosine Kinase (BTK) Inhibition Promotes Myelin Repair in Two Different Models of Demyelination (3983)
122. Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
123. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis
124. Modafinil for the treatment of fatigue in multiple sclerosis
125. Evaluation of CSF1R‐related adult onset leukoencephalopathy with axonal spheroids and pigmented glia diagnostic criteria.
126. Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.
127. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders.
128. Recréer in vivoà partir de l’IRM clinique des cartographies spécifiques du contenu myélinique dérivées de la TEP grâce à l’Intelligence artificielle générative chez les patients atteints de SEP
129. From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
130. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia
131. Nuclear bilateral Bell's palsy and ageusia associated with Mycoplasma pneumoniae pulmonary infection
132. Association of Caspr/paranodin with tumour suppressor schwannomin/merlin and β1 integrin in the central nervous system
133. Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy
134. Untreated patients with multiple sclerosis: A study of French expert centers.
135. MSJ815602_Annex_1 – Supplemental material for Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France
136. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB
137. Thalamic Energy Dysregulation Drives Microstructural Changes Of Thalamo-Cortical Projections In Multiple Sclerosis (P2.2-061)
138. Multicenter Validation Of Population-Based Input Function With Non-Linear Mixed Effect Modeling For Voxel-Wise Quantification Of [18F]Fdg Metabolic Rate
139. Dynamic 11C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis
140. PET is necessary to make the next step forward in understanding MS pathophysiology – Yes
141. Fluid-attenuated inversion recovery MRI synthesis from multisequence MRI using three-dimensional fully convolutional networks for multiple sclerosis
142. Ultrahigh field imaging of myelin disease models: Toward specific markers of myelin integrity?
143. Dynamic 11C-PiB PET shows cerebrospinal fluid flow alterations in Alzheimer’s disease and multiple sclerosis
144. Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France
145. Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?
146. Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
147. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714
148. Natalizumab-PML survivors with subsequent MS treatment
149. Unexpected aggravation of Parkinson’s disease by a mesencephalic multiple sclerosis lesion
150. Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.